Skip to content

Clinical trials

Phase 1/2 Brain Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Phase: Phase 1/2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20171
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AC Immune SA1
BBB-Therapeutics B.V.1
Forge Biologics, Inc1
M.D. Anderson Cancer Center1
Stemline Therapeutics, Inc.1
TVAX Biomedical1
Thomas Advanced Medical LLC1
Titan Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases8
Central Nervous System Diseases8
Brain Neoplasms4
Nervous System Diseases4
Central Nervous System Neoplasms3
Neoplasms3
Alzheimer Disease2
Breast Neoplasms2
Dementia2
Glioma2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.